ݺߣshows by User: Mohdsharshir / http://www.slideshare.net/images/logo.gif ݺߣshows by User: Mohdsharshir / Sun, 08 Nov 2020 11:36:45 GMT ݺߣShare feed for ݺߣshows by User: Mohdsharshir Sodium glucose cotransporter 2 (sglt2) inhibitors /slideshow/sodium-glucose-cotransporter-2-sglt2-inhibitors/239148434 sodiumglucosecotransporter2sglt2inhibitors-201108113645
Sodium glucose cotransporter 2 (sglt2) inhibitors and the effect on the heart and chronic kidney disease. ]]>
Sodium glucose cotransporter 2 (sglt2) inhibitors and the effect on the heart and chronic kidney disease. ]]> Sun, 08 Nov 2020 11:36:45 GMT /slideshow/sodium-glucose-cotransporter-2-sglt2-inhibitors/239148434 Mohdsharshir@slideshare.net(Mohdsharshir) Sodium glucose cotransporter 2 (sglt2) inhibitors Mohdsharshir Sodium glucose cotransporter 2 (sglt2) inhibitors and the effect on the heart and chronic kidney disease. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/sodiumglucosecotransporter2sglt2inhibitors-201108113645-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Sodium glucose cotransporter 2 (sglt2) inhibitors and the effect on the heart and chronic kidney disease.
Sodium glucose cotransporter 2 (sglt2) inhibitors from Moh'd sharshir
]]> 2218 0 https://cdn.slidesharecdn.com/ss_thumbnails/sodiumglucosecotransporter2sglt2inhibitors-201108113645-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Sunitinib for the pancreatic neuroendocrine tumors, Moh'd sharshir /slideshow/sunitinib-for-the-pancreatic-neuroendocrine-tumors-mohd-sharshir/101796727 sunitinibforthepancreaticneuroendocrinetumors-180611010249
Sunitinib for the pancreatic neuroendocrine tumors]]>
Sunitinib for the pancreatic neuroendocrine tumors]]> Mon, 11 Jun 2018 01:02:49 GMT /slideshow/sunitinib-for-the-pancreatic-neuroendocrine-tumors-mohd-sharshir/101796727 Mohdsharshir@slideshare.net(Mohdsharshir) Sunitinib for the pancreatic neuroendocrine tumors, Moh'd sharshir Mohdsharshir Sunitinib for the pancreatic neuroendocrine tumors <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/sunitinibforthepancreaticneuroendocrinetumors-180611010249-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Sunitinib for the pancreatic neuroendocrine tumors
Sunitinib for the pancreatic neuroendocrine tumors, Moh'd sharshir from Moh'd sharshir
]]> 428 5 https://cdn.slidesharecdn.com/ss_thumbnails/sunitinibforthepancreaticneuroendocrinetumors-180611010249-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Management of oncology emergencies, Mohh'd sharshir /slideshow/management-of-oncology-emergencies-mohhd-sharshir/101796422 managementofoncologyemergencies-180611005944
Management of oncology emergencies]]>
Management of oncology emergencies]]> Mon, 11 Jun 2018 00:59:44 GMT /slideshow/management-of-oncology-emergencies-mohhd-sharshir/101796422 Mohdsharshir@slideshare.net(Mohdsharshir) Management of oncology emergencies, Mohh'd sharshir Mohdsharshir Management of oncology emergencies <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/managementofoncologyemergencies-180611005944-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Management of oncology emergencies
Management of oncology emergencies, Mohh'd sharshir from Moh'd sharshir
]]> 1732 6 https://cdn.slidesharecdn.com/ss_thumbnails/managementofoncologyemergencies-180611005944-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE, ProMISe, Moh'd sharshir /slideshow/early-goaldirected-therapy-in-severe-sepsis-and-septic-shock-process-arise-promise-mohd-sharshir/101795096 egdtforsepticshock1-180611004626
Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE, ProMISe]]>
Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE, ProMISe]]> Mon, 11 Jun 2018 00:46:26 GMT /slideshow/early-goaldirected-therapy-in-severe-sepsis-and-septic-shock-process-arise-promise-mohd-sharshir/101795096 Mohdsharshir@slideshare.net(Mohdsharshir) Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE, ProMISe, Moh'd sharshir Mohdsharshir Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE, ProMISe <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/egdtforsepticshock1-180611004626-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE, ProMISe
Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE, ProMISe, Moh'd sharshir from Moh'd sharshir
]]> 1331 9 https://cdn.slidesharecdn.com/ss_thumbnails/egdtforsepticshock1-180611004626-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Bathing of critically ill patients with chlorhexidine decreases hospital acquired BSIs, Moh'd sharshir /slideshow/bathing-of-critically-ill-patients-with-chlorhexidine-decreases-hospital-acquired-bsis-mohd-sharshir/101780151 bathingofcriticallyillpatientswithchlorhexidinedecreaseshospital-acquiredbsis-180610221704
bathing of critically ill patients with chlorhexidine decreases hospital-acquired BSIs ]]>
bathing of critically ill patients with chlorhexidine decreases hospital-acquired BSIs ]]> Sun, 10 Jun 2018 22:17:04 GMT /slideshow/bathing-of-critically-ill-patients-with-chlorhexidine-decreases-hospital-acquired-bsis-mohd-sharshir/101780151 Mohdsharshir@slideshare.net(Mohdsharshir) Bathing of critically ill patients with chlorhexidine decreases hospital acquired BSIs, Moh'd sharshir Mohdsharshir bathing of critically ill patients with chlorhexidine decreases hospital-acquired BSIs <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/bathingofcriticallyillpatientswithchlorhexidinedecreaseshospital-acquiredbsis-180610221704-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> bathing of critically ill patients with chlorhexidine decreases hospital-acquired BSIs
Bathing of critically ill patients with chlorhexidine decreases hospital acquired BSIs, Moh'd sharshir from Moh'd sharshir
]]> 170 3 https://cdn.slidesharecdn.com/ss_thumbnails/bathingofcriticallyillpatientswithchlorhexidinedecreaseshospital-acquiredbsis-180610221704-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Case presentation, meningitis and treatment, Moh'd Sharshir /slideshow/case-presentation-meningitis-and-treatment/101726607 casepresentationmeningitis-180610065229
Case presentation, meningitis and treatment]]>
Case presentation, meningitis and treatment]]> Sun, 10 Jun 2018 06:52:29 GMT /slideshow/case-presentation-meningitis-and-treatment/101726607 Mohdsharshir@slideshare.net(Mohdsharshir) Case presentation, meningitis and treatment, Moh'd Sharshir Mohdsharshir Case presentation, meningitis and treatment <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/casepresentationmeningitis-180610065229-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Case presentation, meningitis and treatment
Case presentation, meningitis and treatment, Moh'd Sharshir from Moh'd sharshir
]]> 5162 6 https://cdn.slidesharecdn.com/ss_thumbnails/casepresentationmeningitis-180610065229-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Aortic dissection, pathophysiology, risk, incidence, types and treatment, Moh'd Sharshir /slideshow/aortic-dissection-pathophysiology-risk-incidence-types-and-treatment/101726445 aorticdissection-180610064636
Aortic dissection, pathophysiology, risk, incidence, types and treatment]]>
Aortic dissection, pathophysiology, risk, incidence, types and treatment]]> Sun, 10 Jun 2018 06:46:36 GMT /slideshow/aortic-dissection-pathophysiology-risk-incidence-types-and-treatment/101726445 Mohdsharshir@slideshare.net(Mohdsharshir) Aortic dissection, pathophysiology, risk, incidence, types and treatment, Moh'd Sharshir Mohdsharshir Aortic dissection, pathophysiology, risk, incidence, types and treatment <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/aorticdissection-180610064636-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Aortic dissection, pathophysiology, risk, incidence, types and treatment
Aortic dissection, pathophysiology, risk, incidence, types and treatment, Moh'd Sharshir from Moh'd sharshir
]]> 2924 8 https://cdn.slidesharecdn.com/ss_thumbnails/aorticdissection-180610064636-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Adjuvant systemic therapy in resectable non-small cell lung cancer, Moh'd sharshir /Mohdsharshir/adjuvant-systemic-therapy-in-resectable-nonsmall-cell-lung-cancer adjuvantinnsclc-180610064338
Adjuvant systemic therapy in resectable non-small cell lung cancer]]>
Adjuvant systemic therapy in resectable non-small cell lung cancer]]> Sun, 10 Jun 2018 06:43:38 GMT /Mohdsharshir/adjuvant-systemic-therapy-in-resectable-nonsmall-cell-lung-cancer Mohdsharshir@slideshare.net(Mohdsharshir) Adjuvant systemic therapy in resectable non-small cell lung cancer, Moh'd sharshir Mohdsharshir Adjuvant systemic therapy in resectable non-small cell lung cancer <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/adjuvantinnsclc-180610064338-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Adjuvant systemic therapy in resectable non-small cell lung cancer
Adjuvant systemic therapy in resectable non-small cell lung cancer, Moh'd sharshir from Moh'd sharshir
]]> 1055 8 https://cdn.slidesharecdn.com/ss_thumbnails/adjuvantinnsclc-180610064338-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 A Randomized Trial of Vitamin D Supplementation on Vascular Function in CKD, Moh'd sharshir /slideshow/a-randomized-trial-of-vitamin-d-supplementation-on-vascular-function-in-ckd/101726183 vitd-180610063958
A Randomized Trial of Vitamin D Supplementation on Vascular Function in CKD]]>
A Randomized Trial of Vitamin D Supplementation on Vascular Function in CKD]]> Sun, 10 Jun 2018 06:39:57 GMT /slideshow/a-randomized-trial-of-vitamin-d-supplementation-on-vascular-function-in-ckd/101726183 Mohdsharshir@slideshare.net(Mohdsharshir) A Randomized Trial of Vitamin D Supplementation on Vascular Function in CKD, Moh'd sharshir Mohdsharshir A Randomized Trial of Vitamin D Supplementation on Vascular Function in CKD <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/vitd-180610063958-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> A Randomized Trial of Vitamin D Supplementation on Vascular Function in CKD
A Randomized Trial of Vitamin D Supplementation on Vascular Function in CKD, Moh'd sharshir from Moh'd sharshir
]]> 123 4 https://cdn.slidesharecdn.com/ss_thumbnails/vitd-180610063958-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia, Moh'd sharshir /slideshow/efcacy-of-febuxostat-for-slowing-the-gfr-decline-in-patients-with-ckd-and-asymptomatic-hyperuricemia/101726027 febuxostat-180610063620
Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia]]>
Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia]]> Sun, 10 Jun 2018 06:36:19 GMT /slideshow/efcacy-of-febuxostat-for-slowing-the-gfr-decline-in-patients-with-ckd-and-asymptomatic-hyperuricemia/101726027 Mohdsharshir@slideshare.net(Mohdsharshir) Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia, Moh'd sharshir Mohdsharshir Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/febuxostat-180610063620-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia
Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia, Moh'd sharshir from Moh'd sharshir
]]> 214 5 https://cdn.slidesharecdn.com/ss_thumbnails/febuxostat-180610063620-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 kidney disease in HIV-positive patients, Moh'd sharshir /slideshow/kidney-disease-in-hivpositive-patients/101725850 hivnephropathy-180610063228
kidney disease in HIV-positive patients]]>
kidney disease in HIV-positive patients]]> Sun, 10 Jun 2018 06:32:28 GMT /slideshow/kidney-disease-in-hivpositive-patients/101725850 Mohdsharshir@slideshare.net(Mohdsharshir) kidney disease in HIV-positive patients, Moh'd sharshir Mohdsharshir kidney disease in HIV-positive patients <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/hivnephropathy-180610063228-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> kidney disease in HIV-positive patients
kidney disease in HIV-positive patients, Moh'd sharshir from Moh'd sharshir
]]> 1955 7 https://cdn.slidesharecdn.com/ss_thumbnails/hivnephropathy-180610063228-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes, Moh'd sharshir /slideshow/liraglutide-and-cardiovascular-outcomes-in-type-2-diabetes/101725685 liraglutide-180610062831
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes]]>
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes]]> Sun, 10 Jun 2018 06:28:31 GMT /slideshow/liraglutide-and-cardiovascular-outcomes-in-type-2-diabetes/101725685 Mohdsharshir@slideshare.net(Mohdsharshir) Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes, Moh'd sharshir Mohdsharshir Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/liraglutide-180610062831-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes, Moh'd sharshir from Moh'd sharshir
]]> 694 12 https://cdn.slidesharecdn.com/ss_thumbnails/liraglutide-180610062831-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Therapy of focal or diffuse proliferative lupus nephritis, Moh'd sharshir /slideshow/therapy-of-focal-or-diffuse-proliferative-lupus-nephritis/101725477 lupusnephritis-180610062405
Therapy of focal or diffuse proliferative lupus nephritis]]>
Therapy of focal or diffuse proliferative lupus nephritis]]> Sun, 10 Jun 2018 06:24:05 GMT /slideshow/therapy-of-focal-or-diffuse-proliferative-lupus-nephritis/101725477 Mohdsharshir@slideshare.net(Mohdsharshir) Therapy of focal or diffuse proliferative lupus nephritis, Moh'd sharshir Mohdsharshir Therapy of focal or diffuse proliferative lupus nephritis <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/lupusnephritis-180610062405-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Therapy of focal or diffuse proliferative lupus nephritis
Therapy of focal or diffuse proliferative lupus nephritis, Moh'd sharshir from Moh'd sharshir
]]> 346 6 https://cdn.slidesharecdn.com/ss_thumbnails/lupusnephritis-180610062405-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 NephMadness 2017: Diabetic Nephropathy Region /slideshow/nephmadness-2017-diabetic-nephropathyregion/101725320 nephmadnessdm-180610062035
NephMadness 2017: Diabetic Nephropathy Region]]>
NephMadness 2017: Diabetic Nephropathy Region]]> Sun, 10 Jun 2018 06:20:35 GMT /slideshow/nephmadness-2017-diabetic-nephropathyregion/101725320 Mohdsharshir@slideshare.net(Mohdsharshir) NephMadness 2017: Diabetic Nephropathy Region Mohdsharshir NephMadness 2017: Diabetic Nephropathy Region <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/nephmadnessdm-180610062035-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> NephMadness 2017: Diabetic Nephropathy Region
NephMadness 2017: Diabetic Nephropathy Region from Moh'd sharshir
]]> 252 8 https://cdn.slidesharecdn.com/ss_thumbnails/nephmadnessdm-180610062035-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Multitarget Therapy for InductionTreatment of Lupus Nephritis, Moh'd sharshir /slideshow/multitarget-therapy-for-inductiontreatment-of-lupus-nephritis/101724751 sle-180610060754
Multitarget Therapy for Induction Treatment of Lupus Nephritis]]>
Multitarget Therapy for Induction Treatment of Lupus Nephritis]]> Sun, 10 Jun 2018 06:07:54 GMT /slideshow/multitarget-therapy-for-inductiontreatment-of-lupus-nephritis/101724751 Mohdsharshir@slideshare.net(Mohdsharshir) Multitarget Therapy for InductionTreatment of Lupus Nephritis, Moh'd sharshir Mohdsharshir Multitarget Therapy for Induction Treatment of Lupus Nephritis <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/sle-180610060754-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Multitarget Therapy for Induction Treatment of Lupus Nephritis
Multitarget Therapy for InductionTreatment of Lupus Nephritis, Moh'd sharshir from Moh'd sharshir
]]> 202 3 https://cdn.slidesharecdn.com/ss_thumbnails/sle-180610060754-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Use of lung ultrasonography to determine the accuracy of clinically estimated dry weight in chronic hemodialysis patients, Moh'd sharshir /slideshow/use-oflung-ultrasonography-todetermine-theaccuracy-ofclinically-estimated-dry-weight-inchronic-hemodialysis-patients/101724525 lungus-180610060302
Use of lung ultrasonography to determine the accuracy of clinically estimated dry weight in chronic hemodialysis patients]]>
Use of lung ultrasonography to determine the accuracy of clinically estimated dry weight in chronic hemodialysis patients]]> Sun, 10 Jun 2018 06:03:02 GMT /slideshow/use-oflung-ultrasonography-todetermine-theaccuracy-ofclinically-estimated-dry-weight-inchronic-hemodialysis-patients/101724525 Mohdsharshir@slideshare.net(Mohdsharshir) Use of lung ultrasonography to determine the accuracy of clinically estimated dry weight in chronic hemodialysis patients, Moh'd sharshir Mohdsharshir Use of lung ultrasonography to determine the accuracy of clinically estimated dry weight in chronic hemodialysis patients <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/lungus-180610060302-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Use of lung ultrasonography to determine the accuracy of clinically estimated dry weight in chronic hemodialysis patients
Use of lung ultrasonography to determine the accuracy of clinically estimated dry weight in chronic hemodialysis patients, Moh'd sharshir from Moh'd sharshir
]]> 135 5 https://cdn.slidesharecdn.com/ss_thumbnails/lungus-180610060302-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Novel oral anticoagulants in CKD review, Moh'd sharshir /slideshow/novel-oral-anticoagulants-in-ckd-review/101724265 noveloralanticoagulantsinckdreview2018-180610055725
Novel oral anticoagulants in CKD review]]>
Novel oral anticoagulants in CKD review]]> Sun, 10 Jun 2018 05:57:24 GMT /slideshow/novel-oral-anticoagulants-in-ckd-review/101724265 Mohdsharshir@slideshare.net(Mohdsharshir) Novel oral anticoagulants in CKD review, Moh'd sharshir Mohdsharshir Novel oral anticoagulants in CKD review <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/noveloralanticoagulantsinckdreview2018-180610055725-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Novel oral anticoagulants in CKD review
Novel oral anticoagulants in CKD review, Moh'd sharshir from Moh'd sharshir
]]> 485 5 https://cdn.slidesharecdn.com/ss_thumbnails/noveloralanticoagulantsinckdreview2018-180610055725-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Delayed Graft Function post kidney transplant, Moh'd sharshir /slideshow/delayed-graft-function-post-kidney-transplant/101724048 dgf-180610055234
Delayed Graft Function post kidney transplant]]>
Delayed Graft Function post kidney transplant]]> Sun, 10 Jun 2018 05:52:34 GMT /slideshow/delayed-graft-function-post-kidney-transplant/101724048 Mohdsharshir@slideshare.net(Mohdsharshir) Delayed Graft Function post kidney transplant, Moh'd sharshir Mohdsharshir Delayed Graft Function post kidney transplant <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/dgf-180610055234-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Delayed Graft Function post kidney transplant
Delayed Graft Function post kidney transplant, Moh'd sharshir from Moh'd sharshir
]]> 531 6 https://cdn.slidesharecdn.com/ss_thumbnails/dgf-180610055234-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 CKD and pregnancy, Moh'd sharshir /slideshow/ckd-and-pregnancy/101723940 ckdandpregnancy-180610055006
CKD and pregnancy]]>
CKD and pregnancy]]> Sun, 10 Jun 2018 05:50:06 GMT /slideshow/ckd-and-pregnancy/101723940 Mohdsharshir@slideshare.net(Mohdsharshir) CKD and pregnancy, Moh'd sharshir Mohdsharshir CKD and pregnancy <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ckdandpregnancy-180610055006-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> CKD and pregnancy
CKD and pregnancy, Moh'd sharshir from Moh'd sharshir
]]> 585 4 https://cdn.slidesharecdn.com/ss_thumbnails/ckdandpregnancy-180610055006-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Donor-derived cell-free DNA(dd-cfDNA), Moh'd sharshir /slideshow/donorderived-cellfree-dnaddcfdna/101723757 cfdna-180610054625
Donor-derived cell-free DNA(dd-cfDNA) ]]>
Donor-derived cell-free DNA(dd-cfDNA) ]]> Sun, 10 Jun 2018 05:46:25 GMT /slideshow/donorderived-cellfree-dnaddcfdna/101723757 Mohdsharshir@slideshare.net(Mohdsharshir) Donor-derived cell-free DNA(dd-cfDNA), Moh'd sharshir Mohdsharshir Donor-derived cell-free DNA(dd-cfDNA) <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/cfdna-180610054625-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Donor-derived cell-free DNA(dd-cfDNA)
Donor-derived cell-free DNA(dd-cfDNA), Moh'd sharshir from Moh'd sharshir
]]> 428 2 https://cdn.slidesharecdn.com/ss_thumbnails/cfdna-180610054625-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://public.slidesharecdn.com/v2/images/profile-picture.png https://cdn.slidesharecdn.com/ss_thumbnails/sodiumglucosecotransporter2sglt2inhibitors-201108113645-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/sodium-glucose-cotransporter-2-sglt2-inhibitors/239148434 Sodium glucose cotrans... https://cdn.slidesharecdn.com/ss_thumbnails/sunitinibforthepancreaticneuroendocrinetumors-180611010249-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/sunitinib-for-the-pancreatic-neuroendocrine-tumors-mohd-sharshir/101796727 Sunitinib for the panc... https://cdn.slidesharecdn.com/ss_thumbnails/managementofoncologyemergencies-180611005944-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/management-of-oncology-emergencies-mohhd-sharshir/101796422 Management of oncology...